Milbemycin A4 oxime is a semi-synthetic macrocyclic lactone prepared by the oxidation and oximation of milbemycin A4. Milbemycin A4 oxime is the major component (~70%) in the commercial product, milbemycin oxime, marketed for endo- and exo-parasite infections.